SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?


To: Kelly who wrote (3136)9/17/1999 2:43:00 PM
From: Kevin Podsiadlik  Read Replies (1) | Respond to of 19428
 
Maybe we can start with what we're given, about $60 (say $50-70), drug related, small enough to take a 90% shave off of one FDA ruling (say under $4B cap). That yields a fairly select list:

Sepracor (SEPR) - very popular among short sellers, insiders mostly bailed
Andrx (ADRX) - don't know much, other than a lawsuit against...
Biovail (BVF) - One of Asensio's targets